Cargando…
Cannabis medicinal: puntos críticos para su uso clínico
Since ancient times cannabis has been used for recreational and medicinal purposes. It is a significant source of chemical compounds, most of them called phytocannabinoids. These compounds have several physiological effects and produce their effects primarily by binding to endogenous cannabinoid rec...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Nacional de Salud
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536813/ https://www.ncbi.nlm.nih.gov/pubmed/36122285 http://dx.doi.org/10.7705/biomedica.6468 |
_version_ | 1784803060143357952 |
---|---|
author | Gómez-García, Diego Mauricio García-Perdomo, Herney Andrés |
author_facet | Gómez-García, Diego Mauricio García-Perdomo, Herney Andrés |
author_sort | Gómez-García, Diego Mauricio |
collection | PubMed |
description | Since ancient times cannabis has been used for recreational and medicinal purposes. It is a significant source of chemical compounds, most of them called phytocannabinoids. These compounds have several physiological effects and produce their effects primarily by binding to endogenous cannabinoid receptors such as CB1 and CB2, among others. Cannabis has potential therapeutic properties and its preparations have been used as traditional remedies to treat pain and emesis. Synthetic cannabinoids are used clinically as analgesics, antispastics, antiemetics, and appetite stimulants. Significant cannabis toxicity is rare in adults; however, it can produce countless acute and chronic side effects. The quality of the evidence in this field is limited by the short duration of the trials, poor sample sizes, lack of a control group, and the existence of bias in most of the reviewed studies. Therefore, a larger number of studies with better methodological quality is required to support the safe use of this therapy. The decision to include cannabinoids as a treatment for any of the conditions described will depend on the evidence, the use of previous therapies, and the type of patient. |
format | Online Article Text |
id | pubmed-9536813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Instituto Nacional de Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-95368132022-10-07 Cannabis medicinal: puntos críticos para su uso clínico Gómez-García, Diego Mauricio García-Perdomo, Herney Andrés Biomedica Comentario Since ancient times cannabis has been used for recreational and medicinal purposes. It is a significant source of chemical compounds, most of them called phytocannabinoids. These compounds have several physiological effects and produce their effects primarily by binding to endogenous cannabinoid receptors such as CB1 and CB2, among others. Cannabis has potential therapeutic properties and its preparations have been used as traditional remedies to treat pain and emesis. Synthetic cannabinoids are used clinically as analgesics, antispastics, antiemetics, and appetite stimulants. Significant cannabis toxicity is rare in adults; however, it can produce countless acute and chronic side effects. The quality of the evidence in this field is limited by the short duration of the trials, poor sample sizes, lack of a control group, and the existence of bias in most of the reviewed studies. Therefore, a larger number of studies with better methodological quality is required to support the safe use of this therapy. The decision to include cannabinoids as a treatment for any of the conditions described will depend on the evidence, the use of previous therapies, and the type of patient. Instituto Nacional de Salud 2022-09-02 /pmc/articles/PMC9536813/ /pubmed/36122285 http://dx.doi.org/10.7705/biomedica.6468 Text en https://creativecommons.org/licenses/by/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons |
spellingShingle | Comentario Gómez-García, Diego Mauricio García-Perdomo, Herney Andrés Cannabis medicinal: puntos críticos para su uso clínico |
title | Cannabis medicinal: puntos críticos para su uso clínico |
title_full | Cannabis medicinal: puntos críticos para su uso clínico |
title_fullStr | Cannabis medicinal: puntos críticos para su uso clínico |
title_full_unstemmed | Cannabis medicinal: puntos críticos para su uso clínico |
title_short | Cannabis medicinal: puntos críticos para su uso clínico |
title_sort | cannabis medicinal: puntos críticos para su uso clínico |
topic | Comentario |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536813/ https://www.ncbi.nlm.nih.gov/pubmed/36122285 http://dx.doi.org/10.7705/biomedica.6468 |
work_keys_str_mv | AT gomezgarciadiegomauricio cannabismedicinalpuntoscriticosparasuusoclinico AT garciaperdomoherneyandres cannabismedicinalpuntoscriticosparasuusoclinico |